Ashton William 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Jun 22, 2021
Insider Transaction Report
Form 4
Ashton William
Director
Transactions
- Sale
Common Stock, $0.001 par value
2021-06-18$4.24/sh−9,000$38,160→ 46,943 total - Award
Common Stock, $0.001 par value
2021-06-17+14,277→ 55,943 total - Award
Stock Option (Right to Buy)
2021-06-17+67,804→ 67,804 totalExercise: $4.29Exp: 2031-06-17→ Common Stock (67,804 underlying)
Footnotes (3)
- [F1]100% of the restricted shares shall vest on the earlier of (1) June 17, 2022 or (2) the date of the company's 2022 Annual Meeting of Stockholders.
- [F2]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
- [F3]One third of the aggregate amount of option shares shall vest on each of June 17, 2022, 2023 and 2024, respectively.